Abstract
The 5,10-methylenetetrahydrofolate reductase (MTHFR) gene 677C→T polymorphism causes an A222V amino acid change which affects MTHFR enzyme activity and can increase homocysteine, a vascular disease risk factor. This polymorphism was examined for association with stroke. In a case-control study of 241 ischemic stroke patients and 304 controls in Hong Kong, the V allele increased in stroke [28% vs. 20%, odds ratio (OR) 1.5, p=0.003]. A lack of significance for the increase in the VV genotype (7.5% vs. 4.6%, OR 1.7, p=0.16) may be due to its rarity in this region. V-allele carriers had more severe strokes (according to the NIH stroke scale). The association of the V allele with stroke occurred mostly in women or older subjects and was due to decreasing V allele frequency with age, as seen in other studies. This V frequency decline with age might be due to a loss of V-carrying controls from a higher risk of cancer, vascular disease, bone fracture, and kidney failure when folate is sparse. Examination of previous studies revealed that the association of VV genotype with stroke appeared stronger in Japan than elsewhere, possibly due to dietary differences. Perhaps folate supplementation for stroke prevention would particularly benefit VV individuals in such high-risk regions.
References
1 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111–3.10.1038/ng0595-111Search in Google Scholar
2 Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22:195–201.10.1016/S0165-6147(00)01675-8Search in Google Scholar
3 Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13:20–33.Search in Google Scholar
4 Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127:212–9.10.1093/brain/awh023Search in Google Scholar PubMed
5 Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. J Am Med Assoc 2002; 288:2023–31.10.1001/jama.288.16.2023Search in Google Scholar PubMed
6 Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicentercase-control study in China. Stroke 2003; 34:2085–90.10.1161/01.STR.0000086753.00555.0DSearch in Google Scholar PubMed
7 Perry IJ. Homocysteine, hypertension and stroke. J Hum Hypertens 1999; 13:289–93.10.1038/sj.jhh.1000803Search in Google Scholar PubMed
8 Woo KS, Qiao M, Chook P, Poon PY, Chan AK, Lau JT, et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention. J Card Surg 2002; 17:432–5.10.1111/j.1540-8191.2001.tb01173.xSearch in Google Scholar
9 Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 677C→Tpolymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 2002; 59:529–36.10.1212/WNL.59.4.529Search in Google Scholar PubMed
10 DeLoughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM, Jr., et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94:3074–8.10.1161/01.CIR.94.12.3074Search in Google Scholar PubMed
11 Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard LT, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999; 10:251–9.10.1097/00001721-199907000-00006Search in Google Scholar PubMed
12 Huang Y, Zhao YY, Li S. [Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke]. Zhonghua Yi Xue Za Zhi 2002; 82:119–22.Search in Google Scholar
13 Kaye JM, Stanton KG, McCann VJ, Vasikaran SD, Burke V, Taylor RR, et al. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects. Clin Sci (Lond) 2002; 102:631–7.10.1042/CS20010323Search in Google Scholar
14 Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003; 146:948–57.10.1016/S0002-8703(03)00519-2Search in Google Scholar
15 Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, Eggertsen G, et al. A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis. Eur J Clin Invest 1998; 28:285–9.10.1046/j.1365-2362.1998.00281.xSearch in Google Scholar
16 Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002; 33:51–6.10.1161/hs0102.100483Search in Google Scholar
17 Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 1997; 28:1739–43.10.1161/01.STR.28.9.1739Search in Google Scholar
18 Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, et al. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 1998; 18:1465–9.10.1161/01.ATV.18.9.1465Search in Google Scholar
19 Passaro A, Vanini A, Calzoni F, Alberti L, Zamboni PF, Fellin R, et al. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 2001; 157:175–80.10.1016/S0021-9150(00)00696-1Search in Google Scholar
20 Press RD, Beamer N, Evans A, DeLoughery TG, Coull BM. Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke. Diagn Mol Pathol 1999; 8:54–8.10.1097/00019606-199903000-00009Search in Google Scholar PubMed
21 Roest M, van der Schouw YT, Grobbee DE, Tempelman MJ, de Groot PG, Sixma JJ, et al. Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. Am J Epidemiol 2001; 153:673–9.10.1093/aje/153.7.673Search in Google Scholar PubMed
22 Todesco L, Angst C, Litynski P, Loehrer F, Fowler B, Haefeli WE. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest 1999; 29:1003–9.10.1046/j.1365-2362.1999.00578.xSearch in Google Scholar PubMed
23 Wu Y, Tomon M, Sumino K. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: sex difference in Japanese. Kobe J Med Sci 2001; 47:255–62.Search in Google Scholar
24 Yoo JH, Choi GD, Kang SS. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 2000; 20:1921–5.10.1161/01.ATV.20.8.1921Search in Google Scholar
25 Zhang G, Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res 2001; 104:187–95.10.1016/S0049-3848(01)00352-8Search in Google Scholar
26 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–97.10.2337/diacare.20.7.1183Search in Google Scholar
27 Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000; 31:2641–7.10.1161/01.STR.31.11.2641Search in Google Scholar
28 Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96:12810–5.10.1073/pnas.96.22.12810Search in Google Scholar
29 Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996; 27:1817–20.10.1161/01.STR.27.10.1817Search in Google Scholar
30 Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, et al. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 2003; 111:39–44.10.1016/j.thromres.2003.08.022Search in Google Scholar
31 Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000; 96:762–4.10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-XSearch in Google Scholar
32 Faure-Delanef L, Quere I, Chasse JF, Guerassimenko O, Lesaulnier M, Bellet H, et al. Methylenetetrahydrofolate reductase thermolabile variant and human longevity. Am J Hum Genet 1997; 60:999–1001.Search in Google Scholar
33 Matsushita S, Muramatsu T, Arai H, Matsui T, Higuchi S. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet 1997; 61:1459–60.10.1086/301640Search in Google Scholar
34 Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 2002; 50:520–4.10.1136/gut.50.4.520Search in Google Scholar
35 Rees DC, Liu YT, Cox MJ, Elliott P, Wainscoat JS. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age. Thromb Haemost 1997; 78:1357–9.10.1055/s-0038-1665411Search in Google Scholar
36 Bladbjerg EM, Andersen-Ranberg K, de Maat MP, Kristensen SR, Jeune B, Gram J, et al. Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost 1999; 82:1100–5.10.1055/s-0037-1614336Search in Google Scholar
37 Hessner MJ, Dinauer DM, Kwiatkowski R, Neri B, Raife TJ. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. Clin Chem 2001; 47:1879–84.10.1093/clinchem/47.10.1879Search in Google Scholar
38 Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case–control study. Int J Cancer 2001; 95:332–6.Search in Google Scholar
39 Miao X, Xing D, Tan W, Qi J, Lu W, Lin D. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 2002; 11:1454–8.Search in Google Scholar
40 Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 2003; 10:1615–23.10.3892/or.10.5.1615Search in Google Scholar
41 Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003; 157:571–82.10.1093/aje/kwg024Search in Google Scholar PubMed
42 Bathum L, Von Bornemann HJ, Christiansen L, Madsen JS, Skytthe A, Christensen K. Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study. Osteoporos Int 2004; 15;659–64.10.1007/s00198-003-1584-zSearch in Google Scholar PubMed
43 Song C, Xing D, Tan W, Wei Q, Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61:3272–5.Search in Google Scholar
44 Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12:1222–6.Search in Google Scholar
45 Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103:252–7.10.1182/blood-2003-06-1794Search in Google Scholar PubMed
46 Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002; 70:758–62.10.1086/338932Search in Google Scholar PubMed PubMed Central
47 Reyes-Engel A, Munoz E, Gaitan MJ, Fabre E, Gallo M, Dieguez JL, et al. Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod 2002; 8:952–7.10.1093/molehr/8.10.952Search in Google Scholar PubMed
48 Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000; 67:986–90.10.1086/303082Search in Google Scholar PubMed PubMed Central
49 Harmon DL, Doyle RM, Meleady R, Doyle M, Shields DC, Barry R, et al. Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler Thromb Vasc Biol 1999; 19:208–11.10.1161/01.ATV.19.2.208Search in Google Scholar
50 Notsu Y, Nabika T, Park HY, Masuda J, Kobayashi S. Evaluation of genetic risk factors for silent brain infarction. Stroke 1999; 30:1881–6.10.1161/01.STR.30.9.1881Search in Google Scholar PubMed
51 Topic E, Timundic AM, Ttefanovic M, Demarin V, Vukovic V, Lovrencic-Huzjan A, et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001; 39:346–50.10.1515/CCLM.2001.054Search in Google Scholar PubMed
52 Malnick S, Goland S. Folic acid as ultimate in disease prevention: beware of vitamin B12 deficiency. Br Med J 2004; 328:769.10.1136/bmj.328.7442.769Search in Google Scholar PubMed PubMed Central
53 Hornberger J. A cost–benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example. Am J Public Health 1998; 88:61–7.10.2105/AJPH.88.1.61Search in Google Scholar
54 Xue Y, Yu J, Wan Q, Fu S, Cheng F, Huang C, et al. Distribution of a common methylenetetrahydrofolate mutation in six Chinese population groups. Anthropol Anz 2000; 58:253–7.10.1127/anthranz/58/2000/253Search in Google Scholar
55 Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998; 62:1258–60.10.1086/301836Search in Google Scholar PubMed PubMed Central
56 Kiffmeyer WR, Langer E, Davies SM, Envall J, Robison LL, Ross JA. Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival. Cancer 2004; 100:411–7.10.1002/cncr.11913Search in Google Scholar PubMed
57 de Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91:3562–5.10.1182/blood.V91.10.3562Search in Google Scholar
58 Mukherjee M, Joshi S, Bagadi S, Dalvi M, Rao A, Shetty KR. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 2002; 61:155–9.10.1034/j.1399-0004.2002.610212.xSearch in Google Scholar PubMed
59 Li C, Zhang C, Qiu S, Lu X, Zeng Y, Wu H, et al. Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic strok. Zhonghua Yi Xue Za Zhi 2002; 82:1046–9.Search in Google Scholar
©2004 by Walter de Gruyter Berlin New York
